ES2094093A1 - Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. - Google Patents

Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.

Info

Publication number
ES2094093A1
ES2094093A1 ES09401999A ES9401999A ES2094093A1 ES 2094093 A1 ES2094093 A1 ES 2094093A1 ES 09401999 A ES09401999 A ES 09401999A ES 9401999 A ES9401999 A ES 9401999A ES 2094093 A1 ES2094093 A1 ES 2094093A1
Authority
ES
Spain
Prior art keywords
magnesium carbonate
basic aluminium
liquid pharmaceutical
stable liquid
pharmaceutical formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09401999A
Other languages
English (en)
Other versions
ES2094093B1 (es
Inventor
Vidal Jose Luis Fabregas
Mauri Jacinto Moragues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Laboratorios Almirall SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Almirall SA filed Critical Laboratorios Almirall SA
Priority to ES9401999A priority Critical patent/ES2094093B1/es
Publication of ES2094093A1 publication Critical patent/ES2094093A1/es
Application granted granted Critical
Publication of ES2094093B1 publication Critical patent/ES2094093B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULACIONES FARMACEUTICAS LIQUIDAS MICROBIOLOGICAMENTE ESTABLES DE CARBONATO BASICO DE ALUMINIO Y MAGNESIO. LAS FORMULACIONES TIENEN COMO COMPONENTE PRINCIPAL EL CARBONATO BASICO DE ALUMINIO Y MAGNESIO, DE FORMULA AL2MG6(OH)14(CO3)2.4 H2O, CONOCIDO COMUNMENTE COMO ALMAGATO Y LLEVAN COMO AGENTES CONSERVANTES ANTIMICROBIANOS A COMPUESTOS DE ESTRUCTURA BIGUANIDINICA, EN CANTIDADES DE ENTRE 0,005 Y 0,05 POR CIENTO, JUNTO CON EXCIPIENTES O DILUYENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE USAN POR VIA ORAL PARA EL TRATAMIENTO DE TRASTORNOS DE TRACTO GASTROINTESTINAL, ESPECIALMENTE LA HIPERACIDEZ GASTRICA.
ES9401999A 1994-09-22 1994-09-22 Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. Expired - Fee Related ES2094093B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9401999A ES2094093B1 (es) 1994-09-22 1994-09-22 Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9401999A ES2094093B1 (es) 1994-09-22 1994-09-22 Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.

Publications (2)

Publication Number Publication Date
ES2094093A1 true ES2094093A1 (es) 1997-01-01
ES2094093B1 ES2094093B1 (es) 1997-08-01

Family

ID=8287515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9401999A Expired - Fee Related ES2094093B1 (es) 1994-09-22 1994-09-22 Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.

Country Status (1)

Country Link
ES (1) ES2094093B1 (es)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139612A (en) * 1971-09-23 1979-02-13 Laboratoires Biotherax Process for making an aluminum phosphate gel
US4425332A (en) * 1978-09-21 1984-01-10 Beecham Group Limited Antacid composition
FR2595249A1 (fr) * 1986-03-10 1987-09-11 Univ Victor Segalen Bordeaux 2 Composition pharmaceutique consistant en une suspension de carbonate de calcium
EP0241804A2 (de) * 1986-04-10 1987-10-21 Bayer Ag Konservierte Antacida-Zubereitungen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139612A (en) * 1971-09-23 1979-02-13 Laboratoires Biotherax Process for making an aluminum phosphate gel
US4425332A (en) * 1978-09-21 1984-01-10 Beecham Group Limited Antacid composition
FR2595249A1 (fr) * 1986-03-10 1987-09-11 Univ Victor Segalen Bordeaux 2 Composition pharmaceutique consistant en une suspension de carbonate de calcium
EP0241804A2 (de) * 1986-04-10 1987-10-21 Bayer Ag Konservierte Antacida-Zubereitungen

Also Published As

Publication number Publication date
ES2094093B1 (es) 1997-08-01

Similar Documents

Publication Publication Date Title
AU6948994A (en) Iron-binding polymers for oral administration
EP0716606A4 (en) PHOSPHATE-BINDING POLYMERS FOR ORAL ADMINISTRATION
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
AU7535798A (en) Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
CA2322644A1 (en) Pharmaceutical composition of topiramate
CA2096575A1 (en) Novel simethicone containing pharmaceutical compositions
IE872400L (en) Pharmaceutical compositions
CA2108455A1 (en) Pharmaceutical compositions against gastric disorders
CA2124677A1 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
AU1252592A (en) Swallowable pharmaceutical compositions
CA2116829A1 (en) Use of a pregnane derivative
CA2114859A1 (en) Cytotoxic and antiviral compound
ES2094093A1 (es) Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.
IE811786L (en) Compositions containing glycosylglucans
CA2122908A1 (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
HUT73500A (en) Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
AU644500B2 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
CA2239423A1 (en) Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
ES2112747A1 (es) Formulaciones farmaceuticas solidas orales para un carbonato basico de aluminio y magnesio con una disponibilidad palatabilidad mejorada.
IL124730A (en) Compositions for the treatment of gastrointestinal disorders comprising a bismuth compound and one or more antimicrobials, and the use of bismuth and an antimicrobial compound for the preparation of such compositions
CA2239433A1 (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970101

Kind code of ref document: A1

Effective date: 19970101

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180806